Cover Image
市場調查報告書

類風濕關節疾病取向標記檢驗產品:開發平台分析

Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Review, 2015

出版商 GlobalData 商品編碼 344269
出版日期 內容資訊 英文 114 Pages
訂單完成後即時交付
價格
Back to Top
類風濕關節疾病取向標記檢驗產品:開發平台分析 Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Review, 2015
出版日期: 2015年10月01日 內容資訊: 英文 114 Pages
簡介

本報告提供全球各國的企業、醫療機關等開發中的、類風濕關節疾病取向標記檢驗產品 (試劑等) 的開發中產品資訊相關分析、臨床實驗/產品開發的整體進展,及各階段/各領域/各地區的詳細趨勢、各企業/各產品的詳細資訊 (臨床實驗的進展階段、開始/結束時期、認證預測等)、近來的產品開發的動向、產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)

第4章 類風濕關節疾病取向標記檢驗產品:現在開發中的開發中產品 (各企業)

  • 類風濕關節疾病取向標記檢驗產品的開發企業:開發中產品 (各開發階段)
  • 類風濕關節疾病取向標記檢驗產品:各開發階段的開發中產品一覽

第5章 類風濕關節疾病取向標記檢驗產品的企業、產品概要

  • Abcodia Ltd.
    • 開發中產品及現在進行中的臨床實驗概要
  • Albert-Ludwigs-Universitat Freiburg
  • Analyticon Biotechnologies AG
  • AnaMar AB
  • Bayerische Patentallianz GmbH
  • Beckman Coulter, Inc.
  • BioSIMS
  • CD Diagnostics, Inc.
  • Chronix Biomedical, Inc.
  • Consejo Superior de Investigaciones Cientificas
  • Crescendo Bioscience, Inc.
  • DIESSE Diagnostica Senese S.p.A.
  • DSX Therapeutics
  • Fundacio Clinic per a la Recerca Biomedica
  • Genalyte, Inc.
  • GeneNews Limited
  • Ghent University
  • Ignyta, Inc.
  • Institut National de la Sante et de la Recherche Medicale
  • KineMed, Inc.
  • Louisville Bioscience, Inc.
  • Myriad Genetics, Inc.
  • Proplex Technologies, Llc
  • Protagen AG
  • Selventa
  • Siemens Healthcare Diagnostics Inc.
  • Singulex, Inc.
  • SomaLogic, Inc.
  • SQI Diagnostics Inc.
  • The Binding Site Group Ltd.
  • The Johns Hopkins University
  • Thermo Fisher Scientific Inc.
  • Toscana Biomarkers Srl
  • University of Aberdeen
  • University of Manchester
  • University of Missouri
  • University of Oxford
  • University of Rochester
  • University of Warwick
  • University Rovira i Virgili

第6章 類風濕關節疾病取向標記檢驗產品:近來的市場趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0088EPD

GlobalData's Medical Devices sector report, "Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Review, 2015" provides an overview of Rheumatoid - Inflammatory Diseases Markers Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Rheumatoid - Inflammatory Diseases Markers Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Rheumatoid - Inflammatory Diseases Markers Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Rheumatoid - Inflammatory Diseases Markers Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Rheumatoid - Inflammatory Diseases Markers Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Rheumatoid - Inflammatory Diseases Markers Tests Overview

3. Products under Development

  • 3.1. Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development
  • 3.2. Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Segment
  • 3.3. Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Territory
  • 3.4. Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Regulatory Path
  • 3.5. Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Estimated Approval Date

4. Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products under Development by Companies

  • 4.1. Rheumatoid - Inflammatory Diseases Markers Tests Companies - Pipeline Products by Stage of Development
  • 4.2. Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development

5. Rheumatoid - Inflammatory Diseases Markers Tests Companies and Product Overview

  • 5.1. Abcodia Ltd. Company Overview
    • 5.1.1. Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Albert-Ludwigs-Universitat Freiburg Company Overview
    • 5.2.1. Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Analyticon Biotechnologies AG Company Overview
    • 5.3.1. Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. AnaMar AB Company Overview
    • 5.4.1. AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Bayerische Patentallianz GmbH Company Overview
    • 5.5.1. Bayerische Patentallianz GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Beckman Coulter, Inc. Company Overview
    • 5.6.1. Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. BioSIMS Company Overview
    • 5.7.1. BioSIMS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. CD Diagnostics, Inc. Company Overview
    • 5.8.1. CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Chronix Biomedical, Inc. Company Overview
    • 5.9.1. Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Consejo Superior de Investigaciones Cientificas Company Overview
    • 5.10.1. Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Crescendo Bioscience, Inc. Company Overview
    • 5.11.1. Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. DIESSE Diagnostica Senese S.p.A. Company Overview
    • 5.12.1. DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. DSX Therapeutics Company Overview
    • 5.13.1. DSX Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Fundacio Clinic per a la Recerca Biomedica Company Overview
    • 5.14.1. Fundacio Clinic per a la Recerca Biomedica Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Genalyte, Inc. Company Overview
    • 5.15.1. Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. GeneNews Limited Company Overview
    • 5.16.1. GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Ghent University Company Overview
    • 5.17.1. Ghent University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Ignyta, Inc. Company Overview
    • 5.18.1. Ignyta, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Institut National de la Sante et de la Recherche Medicale Company Overview
    • 5.19.1. Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. KineMed, Inc. Company Overview
    • 5.20.1. KineMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Louisville Bioscience, Inc. Company Overview
    • 5.21.1. Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Myriad Genetics, Inc. Company Overview
    • 5.22.1. Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Proplex Technologies, Llc Company Overview
    • 5.23.1. Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Protagen AG Company Overview
    • 5.24.1. Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Selventa Company Overview
    • 5.25.1. Selventa Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Siemens Healthcare Diagnostics Inc. Company Overview
    • 5.26.1. Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Singulex, Inc. Company Overview
    • 5.27.1. Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. SomaLogic, Inc. Company Overview
    • 5.28.1. SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. SQI Diagnostics Inc. Company Overview
    • 5.29.1. SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. The Binding Site Group Ltd. Company Overview
    • 5.30.1. The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. The Johns Hopkins University Company Overview
    • 5.31.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Thermo Fisher Scientific Inc. Company Overview
    • 5.32.1. Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Toscana Biomarkers Srl Company Overview
    • 5.33.1. Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. University of Aberdeen Company Overview
    • 5.34.1. University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. University of Manchester Company Overview
    • 5.35.1. University of Manchester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. University of Missouri Company Overview
    • 5.36.1. University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. University of Oxford Company Overview
    • 5.37.1. University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. University of Rochester Company Overview
    • 5.38.1. University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. University of Warwick Company Overview
    • 5.39.1. University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. University Rovira i Virgili Company Overview
    • 5.40.1. University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview

6. Rheumatoid - Inflammatory Diseases Markers Tests- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development
  • Table 2: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Segment
  • Table 3: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Territory
  • Table 4: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Regulatory Path
  • Table 5: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Estimated Approval Date
  • Table 6: Rheumatoid - Inflammatory Diseases Markers Tests Companies - Pipeline Products by Stage of Development
  • Table 7: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development
  • Table 8: Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Molecular Biomarker - Rheumatoid Arthritis - Product Status
  • Table 10: Molecular Biomarker - Rheumatoid Arthritis - Product Description
  • Table 11: Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Diagnostic Kit - Rheumatoid Arthritis - Product Status
  • Table 13: Diagnostic Kit - Rheumatoid Arthritis - Product Description
  • Table 14: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Turbitex ASL - Product Status
  • Table 16: Turbitex ASL - Product Description
  • Table 17: AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: NeoSix Biomarker Assay - Product Status
  • Table 19: NeoSix Biomarker Assay - Product Description
  • Table 20: Bayerische Patentallianz GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Prognostic Test - Rheumatoid Arthritis - Product Status
  • Table 22: Prognostic Test - Rheumatoid Arthritis - Product Description
  • Table 23: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: AU480 Clinical System - anti-CCP Assay - Product Status
  • Table 25: AU480 Clinical System - anti-CCP Assay - Product Description
  • Table 26: AU5810 Clinical System - anti-CCP Assay - Product Status
  • Table 27: AU5810 Clinical System - anti-CCP Assay - Product Description
  • Table 28: AU5820 Clinical System - anti-CCP Assay - Product Status
  • Table 29: AU5820 Clinical System - anti-CCP Assay - Product Description
  • Table 30: AU5830 Clinical System - anti-CCP Assay - Product Status
  • Table 31: AU5830 Clinical System - anti-CCP Assay - Product Description
  • Table 32: AU5840 Clinical System - anti-CCP Assay - Product Status
  • Table 33: AU5840 Clinical System - anti-CCP Assay - Product Description
  • Table 34: AU680 Clinical System - anti-CCP Assay - Product Status
  • Table 35: AU680 Clinical System - anti-CCP Assay - Product Description
  • Table 36: UniCel DxC 600 Synchron Access - anti-CCP Assay - Product Status
  • Table 37: UniCel DxC 600 Synchron Access - anti-CCP Assay - Product Description
  • Table 38: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Status
  • Table 39: UniCel DxC 600i Synchron Access - anti-CCP Assay - Product Description
  • Table 40: UniCel DxC 660i Synchron Access - anti-CCP Assay - Product Status
  • Table 41: UniCel DxC 660i Synchron Access - anti-CCP Assay - Product Description
  • Table 42: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Status
  • Table 43: UniCel DxC 680i Synchron Access Clinical System - anti-CCP Assay - Product Description
  • Table 44: UniCel DxC 800 Synchron Access Clinical System - anti-CCP Assay - Product Status
  • Table 45: UniCel DxC 800 Synchron Access Clinical System - anti-CCP Assay - Product Description
  • Table 46: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Status
  • Table 47: UniCel DxC 860i Synchron Access Clinical System - anti-CCP Assay - Product Description
  • Table 48: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Status
  • Table 49: UniCel DxC 880i Synchron Access Clinical System - anti-CCP Assay - Product Description
  • Table 50: BioSIMS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: DigiPLEX Analyzer - Rheumatology Assay - Product Status
  • Table 52: DigiPLEX Analyzer - Rheumatology Assay - Product Description
  • Table 53: CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Cygnasure Diagnostic Immunoassay - Rheumatoid Arthritis - Product Status
  • Table 55: Cygnasure Diagnostic Immunoassay - Rheumatoid Arthritis - Product Description
  • Table 56: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Companion Diagnostic Test - Rheumatoid Arthritis - Product Status
  • Table 58: Companion Diagnostic Test - Rheumatoid Arthritis - Product Description
  • Table 59: Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Diagnostic Assay - Rheumatoid Arthritis - Product Status
  • Table 61: Diagnostic Assay - Rheumatoid Arthritis - Product Description
  • Table 62: Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: Vectra DA - Product Status
  • Table 64: Vectra DA - Product Description
  • Table 65: DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Screening Kit - Rheumatologic Markers - Product Status
  • Table 67: Screening Kit - Rheumatologic Markers - Product Description
  • Table 68: DSX Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Diagnostic Test - Rheumatoid Arthritis - Product Status
  • Table 70: Diagnostic Test - Rheumatoid Arthritis - Product Description
  • Table 71: Fundacio Clinic per a la Recerca Biomedica Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: Diagnostic Assay - Rheumatoid Arthritis - Product Status
  • Table 73: Diagnostic Assay - Rheumatoid Arthritis - Product Description
  • Table 74: Early Diagnostic Assay - Rheumatoid Arthritis - Product Status
  • Table 75: Early Diagnostic Assay - Rheumatoid Arthritis - Product Description
  • Table 76: Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Maverick Rheumatoid Arthritis Multiplex Assay Kit - Product Status
  • Table 78: Maverick Rheumatoid Arthritis Multiplex Assay Kit - Product Description
  • Table 79: GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Status
  • Table 81: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Description
  • Table 82: Ghent University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: Biomarker Test - Spondyloarthropathy - Product Status
  • Table 84: Biomarker Test - Spondyloarthropathy - Product Description
  • Table 85: Ignyta, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: CLIA Waived Diagnostic Test - Rheumatoid Arthritis - Product Status
  • Table 87: CLIA Waived Diagnostic Test - Rheumatoid Arthritis - Product Description
  • Table 88: TrailblazeDx Test - Rheumatoid Arthritis - Product Status
  • Table 89: TrailblazeDx Test - Rheumatoid Arthritis - Product Description
  • Table 90: TrailblazeTx Test - Rheumatoid Arthritis - Product Status
  • Table 91: TrailblazeTx Test - Rheumatoid Arthritis - Product Description
  • Table 92: Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: Diagnostic Assay - Rheumatoid Arthritis - Product Status
  • Table 94: Diagnostic Assay - Rheumatoid Arthritis - Product Description
  • Table 95: GPI Biomarker Assay - Arthritis - Product Status
  • Table 96: GPI Biomarker Assay - Arthritis - Product Description
  • Table 97: KineMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: Diagnostic Assay - Collagen Synthesis - Product Status
  • Table 99: Diagnostic Assay - Collagen Synthesis - Product Description
  • Table 100: Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 101: Rheumatoid Arthritis pT Autoimmune Test - Product Status
  • Table 102: Rheumatoid Arthritis pT Autoimmune Test - Product Description
  • Table 103: Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: Psoriatic Arthritis - Product Status
  • Table 105: Psoriatic Arthritis - Product Description
  • Table 106: Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 107: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Status
  • Table 108: Biomarker Diagnostic Test - Rheumatoid Arthritis - Product Description
  • Table 109: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Diagnostic Assay - Rheumatoid Arthritis - Product Status
  • Table 111: Diagnostic Assay - Rheumatoid Arthritis - Product Description
  • Table 112: Selventa Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Biomarker Panel - Rheumatoid Arthritis - Product Status
  • Table 114: Biomarker Panel - Rheumatoid Arthritis - Product Description
  • Table 115: Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: ADVIA Centaur CP Immunoassay System - Anti-CCP Assay - Product Status
  • Table 117: ADVIA Centaur CP Immunoassay System - Anti-CCP Assay - Product Description
  • Table 118: ADVIA Centaur XP Immunoassay System - Anti-CCP Assay - Product Status
  • Table 119: ADVIA Centaur XP Immunoassay System - Anti-CCP Assay - Product Description
  • Table 120: ADVIA Centaur XPT Immunoassay System - Anti-CCP Assay - Product Status
  • Table 121: ADVIA Centaur XPT Immunoassay System - Anti-CCP Assay - Product Description
  • Table 122: Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 123: Erenna System - Rheumatoid Arthritis - Product Status
  • Table 124: Erenna System - Rheumatoid Arthritis - Product Description
  • Table 125: SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 126: Somalogic Diagnostic Test - Rheumatoid Arthritis - Product Status
  • Table 127: Somalogic Diagnostic Test - Rheumatoid Arthritis - Product Description
  • Table 128: SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 129: IgX PLEX Rheumatoid Arthritis Panel With Expanded Markers - Product Status
  • Table 130: IgX PLEX Rheumatoid Arthritis Panel With Expanded Markers - Product Description
  • Table 131: The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 132: SPAplus - Rheumatoid Factor Assay - Product Status
  • Table 133: SPAplus - Rheumatoid Factor Assay - Product Description
  • Table 134: The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 135: Anti-PAD4 Based Diagnostic Assay - Rheumatoid Arthritis - Product Status
  • Table 136: Anti-PAD4 Based Diagnostic Assay - Rheumatoid Arthritis - Product Description
  • Table 137: Biomarker Assay - Rheumatoid Arthritis - Product Status
  • Table 138: Biomarker Assay - Rheumatoid Arthritis - Product Description
  • Table 139: Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 140: Phadia 2500 Laboratory System - CCP Test - Product Status
  • Table 141: Phadia 2500 Laboratory System - CCP Test - Product Description
  • Table 142: Phadia 5000 Laboratory System - CCP Test - Product Status
  • Table 143: Phadia 5000 Laboratory System - CCP Test - Product Description
  • Table 144: Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview
  • Table 145: Diagnostic Assay - Rheumatoid Arthritis - Product Status
  • Table 146: Diagnostic Assay - Rheumatoid Arthritis - Product Description
  • Table 147: University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview
  • Table 148: Diagnostic Assay - Rheumatoid Arthritis - Product Status
  • Table 149: Diagnostic Assay - Rheumatoid Arthritis - Product Description
  • Table 150: University of Manchester Pipeline Products & Ongoing Clinical Trials Overview
  • Table 151: Molecular Pathology Test - Rheumatoid Arthritis - Product Status
  • Table 152: Molecular Pathology Test - Rheumatoid Arthritis - Product Description
  • Table 153: University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
  • Table 154: Biomarker Test - Arthritis - Product Status
  • Table 155: Biomarker Test - Arthritis - Product Description
  • Table 156: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • Table 157: Biomarker Based Assay - Rheumatoid Arthritis - Product Status
  • Table 158: Biomarker Based Assay - Rheumatoid Arthritis - Product Description
  • Table 159: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
  • Table 160: PBMC-Based Companion Diagnostic Test - Product Status
  • Table 161: PBMC-Based Companion Diagnostic Test - Product Description
  • Table 162: University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
  • Table 163: Diagnostic Test - Arthritis - Product Status
  • Table 164: Diagnostic Test - Arthritis - Product Description
  • Table 165: University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview
  • Table 166: CD-Medics Test - RA - Product Status
  • Table 167: CD-Medics Test - RA - Product Description
  • Table 168: Glossary

List of Figures

  • Figure 1: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Stage of Development
  • Figure 2: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Segment
  • Figure 3: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Territory
  • Figure 4: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Regulatory Path
  • Figure 5: Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Products by Estimated Approval Date
Back to Top